- Global Pharma News & Resources

Flexitol launches new tool to help address the cost of diabetic foot ulceration

Huddersfield, UK, 19 June 2019 – Flexitol has launched a new cost calculator to determine the cost of diabetic foot ulceration to practices, Clinical Commissioning Groups (CCGs) and Sustainability and Transformation Partnerships (STPs) across England. The tool also advises on how to address diabetic foot problems and ultimately help to cut the expenditures of ulceration and amputation, which have been found to cost NHS England up to almost £1.2bn1 and more than several cancers2. Alongside the launch of the tool, Flexitol has also supported the publication and distribution of the new ‘Capability Framework For Integrated Diabetic Lower Limb Care: A User’s Guide’, an educational material for all healthcare professionals to refer to for the management of diabetic foot conditions.

Using NHS data, the diabetic foot care cost calculator allows practices, CCGs and STPs to calculate how much they are spending on the management and treatment of foot ulceration in people with diabetes in England. Data can be generated at a wider CCG or STP level, or specifically into the cost of diabetic foot ulceration for individual practices. The tool can be accessed through Thornton & Ross representatives and also provides users with recommendations on the use of certain treatments which can help to reduce healthcare professional intervention, and therefore NHS costs. Requests to Thornton & Ross can be made here:

Nathan Mooney, Flexitol’s Senior Brand Manager, says: “We are incredibly pleased to bring our new tool to healthcare providers in England, which we hope will help highlight this issue and ultimately help to reduce the number of diabetic foot complications.”

The launch of the calculator coincides with the publication of the new Capability Framework For Integrated Diabetic Lower Limb Care: A User’s Guide. The framework, developed by a multi-disciplinary working group of specialists from across the UK, including Podiatrists and Nurse Consultants, contains information and guidance for healthcare professionals caring for people with diabetes who have related lower-limb conditions. It also includes details around using urea-based emollients to address certain conditions and is supported by organisations including Diabetes UK, The College of Podiatry and Foot In Diabetes UK.

“We are very proud to have provided an educational grant for the publication of the Capability Framework to help healthcare professionals in caring for people with diabetes and prevent minor foot conditions becoming more serious – including the development of ulcers, which can even lead to amputation.” Commented Nathan Mooney, Senior Brand Manager, Flexitol.

To access the cost calculator, contact the Thornton & Ross sales team here. The capability framework is available here.

– Ends –

About the Flexitol range

Flexitol is the UK’s number one prescribed urea brand, offering a urea-based emollient range for diabetic foot care management; including a 10% urea cream and a 25% urea heel balm to protect and treat diabetic feet, which are both approved by the College of Podiatry.

For further information visit (Health Care professionals only)

About Thornton & Ross

Established in 1922, Thornton & Ross grew to become the largest independent pharmaceutical manufacturer in the UK, before becoming part of the STADA group in 2013.

From a base in Huddersfield, West Yorkshire, Thornton & Ross develop, manufacture and supply a growing portfolio of healthcare products including leading brands such as Flexitol, Covonia, Hedrin, Cetraben and Metanium.


  1. Kerr M (2017) Diabetic foot care in England: An economic study. London: NICE. Available at: Last accessed June 2019
  2. Cost of diabetic foot care higher than several cancers says study. Available at: Last accessed June 2019


Job code: T&R-001-06.19. Date of preparation: June 2019

Editor Details

Last Updated: 25-Jun-2019